Combined Use of Delamanid and Bedaquiline to Treat Multidrug-Resistant and Extensively Drug-Resistant Tuberculosis: A Systematic Review

Target regimen profiles for treatment of tuberculosis: a WHO document

(2017) Christian Lienhardt et al.   EUROPEAN RESPIRATORY JOURNAL

Classifying new anti-tuberculosis drugs: rationale and future perspectives

(2017) Simon Tiberi et al.   INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES

Effectiveness and Safety of Imipenem-Clavulanate Added to an Optimized Background Regimen (OBR) Versus OBR Control Regimens in the Treatment of Multidrug-Resistant and Extensively Drug-Resistant Tuberculosis

(2016) Simon Tiberi et al.   CLINICAL INFECTIOUS DISEASES

Effectiveness and safety of meropenem/clavulanate-containing regimens in the treatment of MDR- and XDR-TB

(2016) Simon Tiberi et al.   EUROPEAN RESPIRATORY JOURNAL

Comparison of effectiveness and safety of imipenem/clavulanate-versusmeropenem/clavulanate-containing regimens in the treatment of MDR- and XDR-TB

(2016) Simon Tiberi et al.   EUROPEAN RESPIRATORY JOURNAL

Cardiac safety of extensively drug-resistant tuberculosis regimens including bedaquiline, delamanid and clofazimine

(2016) Marina Tadolini et al.   EUROPEAN RESPIRATORY JOURNAL

Cardiac safety of extensively drug-resistant tuberculosis regimens including bedaquiline, delamanid and clofazimine

(2016) Robert S. Wallis   EUROPEAN RESPIRATORY JOURNAL

Compassionate use of new drugs in children and adolescents with multidrug-resistant and extensively drug-resistant tuberculosis: early experiences and challenges

(2016) Marina Tadolini et al.   EUROPEAN RESPIRATORY JOURNAL

Faster for less: the new “shorter” regimen for multidrug-resistant tuberculosis

(2016) Giovanni Sotgiu et al.   EUROPEAN RESPIRATORY JOURNAL

New anti-tuberculosis drugs for special populations: a difficult-to-address issue

(2016) Giovanni Sotgiu et al.   EUROPEAN RESPIRATORY JOURNAL

Bedaquiline and multidrug-resistant tuberculosis: a systematic and critical analysis of the evidence

(2016) Emanuele Pontali et al.   EUROPEAN RESPIRATORY JOURNAL

First case of extensively drug-resistant tuberculosis treated with both delamanid and bedaquiline

(2016) Marina Tadolini et al.   EUROPEAN RESPIRATORY JOURNAL

Identification of patients who could benefit from bedaquiline or delamanid: a multisite MDR-TB cohort study

(2016) M. Bonnet et al.   INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE

Bedaquiline plus delamanid for XDR tuberculosis

(2016) Marie Lachâtre et al.   LANCET INFECTIOUS DISEASES

Ertapenem in the treatment of multidrug-resistant tuberculosis: first clinical experience: TABLE 1

(2015) Simon Tiberi et al.   EUROPEAN RESPIRATORY JOURNAL

Tuberculosis elimination, patients' lives and rational use of new drugs: revisited: TABLE 1

(2015) Simon Tiberi et al.   EUROPEAN RESPIRATORY JOURNAL

Classification of antituberculosis drugs: a new proposal based on the most recent evidence

(2015) Jose A. Caminero et al.   EUROPEAN RESPIRATORY JOURNAL

Bedaquiline in the treatment of multidrug- and extensively drug-resistant tuberculosis

(2015) Alexander S. Pym et al.   EUROPEAN RESPIRATORY JOURNAL

Delamanid (OPC-67683) for treatment of multi-drug-resistant tuberculosis

(2015) Giovanni Sotgiu et al.   Expert Review of Anti-Infective Therapy

Compassionate and optimum use of new tuberculosis drugs

(2015) Alberto Matteelli et al.   LANCET INFECTIOUS DISEASES

Linezolid to treat MDR-/XDR-tuberculosis: available evidence and future scenarios

(2015) G. Sotgiu et al.   EUROPEAN RESPIRATORY JOURNAL

Low minimal inhibitory concentrations of linezolid against multidrug-resistant tuberculosis strains

(2015) G. Sotgiu et al.   EUROPEAN RESPIRATORY JOURNAL

ERS/WHO Tuberculosis Consilium assistance with extensively drug-resistant tuberculosis management in a child: case study of compassionate delamanid use

(2014) S. Esposito et al.   EUROPEAN RESPIRATORY JOURNAL

Multidrug-Resistant Tuberculosis and Culture Conversion with Bedaquiline

(2014) Andreas H. Diacon et al.   NEW ENGLAND JOURNAL OF MEDICINE

Linezolid to treat extensively drug-resistant TB: retrospective data are confirmed by experimental evidence: Table 1–

(2013) Giovanni Sotgiu et al.   EUROPEAN RESPIRATORY JOURNAL

Costs of tuberculosis disease in the European Union: a systematic analysis and cost calculation

(2013) R. Diel et al.   EUROPEAN RESPIRATORY JOURNAL

Efficacy, safety and tolerability of linezolid containing regimens in treating MDR-TB and XDR-TB: systematic review and meta-analysis

(2012) Giovanni Sotgiu et al.   EUROPEAN RESPIRATORY JOURNAL

Tuberculosis: cost of illness in Germany

(2012) Roland Diel et al.   EUROPEAN RESPIRATORY JOURNAL

On linezolid efficacy and tolerability

(2012) S. De Lorenzo et al.   EUROPEAN RESPIRATORY JOURNAL

Drug resistance beyond extensively drug-resistant tuberculosis: individual patient data meta-analysis

(2012) Giovanni Battista Migliori et al.   EUROPEAN RESPIRATORY JOURNAL

Efficacy and safety of meropenem–clavulanate added to linezolid-containing regimens in the treatment of MDR-/XDR-TB

(2012) Saverio De Lorenzo et al.   EUROPEAN RESPIRATORY JOURNAL

Resistance to fluoroquinolones and second-line injectable drugs: impact on multidrug-resistant TB outcomes

(2012) Dennis Falzon et al.   EUROPEAN RESPIRATORY JOURNAL

Delamanid improves outcomes and reduces mortality in multidrug-resistant tuberculosis

(2012) Vija Skripconoka et al.   EUROPEAN RESPIRATORY JOURNAL

Delamanid for Multidrug-Resistant Pulmonary Tuberculosis

(2012) Maria Tarcela Gler et al.   NEW ENGLAND JOURNAL OF MEDICINE

Linezolid for Treatment of Chronic Extensively Drug-Resistant Tuberculosis

(2012) Myungsun Lee et al.   NEW ENGLAND JOURNAL OF MEDICINE

Linezolid safety, tolerability and efficacy to treat multidrug- and extensively drug-resistant tuberculosis

(2011) M. Villar et al.   EUROPEAN RESPIRATORY JOURNAL

WHO guidelines for the programmatic management of drug-resistant tuberculosis: 2011 update

(2011) D. Falzon et al.   EUROPEAN RESPIRATORY JOURNAL

The Diarylquinoline TMC207 for Multidrug-Resistant Tuberculosis

(2009) Andreas H. Diacon et al.   NEW ENGLAND JOURNAL OF MEDICINE

Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement

(2009) David Moher et al.   PLOS MEDICINE